Jarrett J Foster

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Both historical clinical and recent preclinical data suggest that the M1 muscarinic acetylcholine receptor is an exciting target for the treatment of Alzheimer's disease and the cognitive and negative symptom clusters in schizophrenia; however, early drug discovery efforts targeting the orthosteric binding site have failed to afford selective M1 activation.(More)
  • 1